HAVCR2 and breast carcinoma: Although the mechanisms which enable breast cancer cells-TIM-3+ to escape the immune response are still poorly described, it has been demonstrated that the TIM-3/galectin-9 pathway is able to protect breast carcinoma cells against cytotoxic T-cell-induced death [41].